Profiles for companies starting with 'x'
✉ Email this page to a colleague
Drugs and US Patents for x
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | PROGESTERONE | progesterone | INJECTABLE;INJECTION | 215634-001 | Jan 5, 2022 | AO | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xiromed | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207849-001 | Oct 1, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xellia Pharms Aps | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | INJECTABLE;INJECTION | 091377-002 | Sep 9, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| X4 Pharms | XOLREMDI | mavorixafor | CAPSULE;ORAL | 218709-001 | Apr 26, 2024 | RX | Yes | Yes | 11,045,461 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Xeris | GVOKE KIT | glucagon | SOLUTION;SUBCUTANEOUS | 212097-005 | Aug 20, 2021 | RX | Yes | Yes | 11,590,205 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Xiromed | ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 207261-001 | Feb 10, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
